Gador, Jhon Laurence B.
HRN: 22-24-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/04/2023
07/11/2023
PO
3ml
BID
PCAP-C; Impetigo
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes